Sarepta Therapeutics (AB3A.MU) Q1 2026 Earnings

25FebConfirmed
Q1 2026
-3.33
-2.56
-1.78
-1.01

Details

Expected EPS
-1.0133706645999998
Actual EPS
-3.3265092
Surprise EPS
-2.31
Surprise Percent
+228.26%

Description

Sarepta Therapeutics (AB3A.MU) has reported earnings of -3.3265092 per share for Q1 2026.

0 Comments

Share your thoughts